TAT GIDA SANAYİ A.Ş.

Share Issue/Capital Change • Dec 21, 2024

Summary Info	CMB Approval Regarding Capital Increase
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Board Decision Date	09.08.2024
Authorized Capital (TL)	250.000.000
Paid-in Capital (TL)	136.000.000
Target Capital (TL)	244.800.000

Rights Issue (Via Preemptive Right)

Share Group Info	Paid-in Capital (TL)	Preemptive Rights Amount (TL)	Preemptive Rights Rate (%)	Preemptive Rights Price	Share Group Issued	New Shares'' ISIN	Form	Preemptive Rights ISIN Code	Unused Rights Amount (TL)	Amount of Shares Cancelled (TL)
TATGD, TRATATKS91A5	136.000.000	108.800.000,000	80,00000	1,00		TATGD, TRATATKS91A5	Registered

	Paid-in Capital (TL)	Preemptive Rights Amount (TL)	Preemptive Rights Rate (%)	Unused Rights Amount (TL)	Amount of Shares Cancelled (TL)
TOTAL	136.000.000	108.800.000,000	80,00000

Currency Unit	TRY

Other Aspects To Be Notified

Capital Market Board Application Date	14.08.2024
Capital Market Board Application Result	Approval
Capital Market Board Approval Date	20.12.2024
Property of Increased Capital Shares	Dematerialized Share

Additional Explanations

Our capital increase application which is regarding the issuance of shares with a nominal value of TRY 108,800,000 due to the increase in our Company's issued capital from TRY 136,000,000 to TRY 244,800,000 within the registered capital ceiling of TRY 250,000,000, with TRY 108,800,000 in cash, was approved by the Capital Markets Board at its 20.12.2024 dated meeting and it was published in the CMB Bulletin dated 20.12.2024 and numbered 2024/57

This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.